VitaNova Life Sciences Corp
corporate_fare Company Profile
VitaNova Life Sciences Corp (OTC:VNOV) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 3 items for VNOV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-14, rated 8/10. Across its 3 most recent items scored 7 or higher, the top rating is 8/10, with 3 rated 8 or above. Recent SEC coverage for VNOV spans 10-Q, 10-K.
Recent high-impact activity:
- VitaNova Q1 Loss Widens 166% as Gross Margin Collapses to 9%
- VitaNova 10-K Exposes Material Weaknesses, Governance Gaps, and Margin Compression Despite Revenue Growth
- VitaNova Reports Q3 Loss, Strong Revenue Growth, and Material Weaknesses in Internal Controls
Financial Snapshot
Short Interest & Short Volume
FINRA reported short interest of 33 shares in VNOV as of the September 15, 2026 settlement, unchanged from the prior period.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.